This is the current SM information sheet (latest version released 3 May 2005) from UK-based vet neurologist Clare Rusbridge, one of the leading researchers into syringomyelia in cavaliers. Information on the cavalier DNA collection project is at the end. Note that they desire blood samples from ANY cavalier, whether it has SM or not, and that the donation benefits research into MVD, epilepsy, and other conditions too. This is posted with Clare Rusbridge's permission.

Support group for people with affected cavaliers or seeking further information:
http://groups.yahoo.com/group/CKCS-SM-support

Syringomyelia

Clare Rusbridge BVMS DipECVN MRCVS


What is Syringomyelia?
Syringomyelia is a condition whereby fluid filled cavities develop within the spinal cord. Some refer to SM as “neck scratcher’s disease” because scratching in the air near the neck is a common sign.

What causes it?
Syringomyelia is a consequence of an obstruction to cerebrospinal fluid (CSF) flow. In the normal mammal, the CSF around the brain shunts back and forth with the arterial pulse. If this rapid efflux and influx is obstructed then the pressure wave is transmitted down the spinal cord distending it immediately below the blockage. This results in the formation of a cavity or syrinx. Syringomyelia can occur from any blockage in the subarachnoid space (space containing CSF around the brain and spinal cord). However, the most common cause is the cerebellum within the foramen magnum (i.e. the back of the brain poking though the hole at the back of the skull). The cerebellum is pushed (herniated) out the skull because there is not enough space since the bone at the back of the skull (occipital bone) is too small. This condition occurs in many small breeds but is common in the cavalier King Charles spaniel (CKCS) (conservative estimates at least 50% of the breed have a degree of occipital hypoplasia although only a proportion are severe enough to have syringomyelia). It is similar to the human condition Chiari malformation (some vets refer to it as Arnold Chiari syndrome which can be confusing as the original description by Arnold was of syringomyelia associated with spina bifida and this is not the case in the CKCS).

What are the clinical signs of syringomyelia?
By far the most important sign of syringomyelia is pain. This is most commonly localised to the neck region but may be difficult to define or intermittent. Owners often report that their dog is worse at night; when first getting up; during hot or cold temperature extremes; when excited; or related to posture e.g. preferring to sleep with their head elevated. They may seem to be overly sensitive to touch on one side of the neck / ear / shoulder / sternum. In addition some affected dogs scratch at one area of the shoulder, ear, neck or sternum. This is typically one side only, while the dog is moving and sometimes without making skin contact
Some dogs, more commonly younger patients, develop a scoliosis (twisted spine). Some severe cases may have other neurological deficits such as fore and hindlimb limb weakness and ataxia (wobbliness). Facial nerve paralysis and deafness have also been associated with the condition.

What age of dog is affected?
Clinical signs of syringomyelia secondary to occipital hypoplasia are usually recognized between 6 months and 3 years of age. However, dogs of any age may be presented and dogs with more severe disease tend to be presented before two years of age.

Do the signs get worse?
Progression of the disease is very variable. Some dogs have the tendency to scratch with mild pain only and other neurological signs, such as paresis, never or very slowly develop. Others can be severely disabled by pain and neurological deficits within 12 months of the first signs developing. Mild syringomyelia may also be found as an incidental finding, with no recognised clinical signs, in the investigation of another neurological disease.

Are there any diseases with similar signs to syringomyelia?
The main diseases to rule out are other causes of neck pain e.g. disc disease (uncommon in dogs less than two years of age); CNS inflammatory diseases and other malformations. If scratching or face rubbing is the main sign then skin disease should be eliminated.

How do I know if my dog has Syringomyelia?
The only way to confirm a diagnosis is by MRI (Magnetic Resonance imaging). This is essentially a picture of the water content of the body presented in a series of slices (like a loaf of bread). Nervous tissue, which contains a lot of water, is not imaged by x-rays but is shown in great detail by MRI. The syringomyelia can be easily visualised as a pocket of fluid within the spinal cord. In severe cases the syrinx is so wide that only a thin rim of spinal cord remains.

If my dog has been diagnosed with Syringomyelia what are the options?
No one can make the decision for you about what is best for your dog.

Medical management
Long-term studies of medical management of syringomyelia are not available yet. The drugs used to treat syringomyelia can be divided into 3 types:
• analgesics;
• drugs which reduce CSF production;
• corticosteroids.

Analgesics
Pain in mild cases may be controlled by non steroidal anti-inflammatory drugs (NSAIDs) e.g. Rimadyl and Metacam. In more severe cases anticonvulsants, which have a neuromodulatory effect on hyperexcitable damaged nervous system, may be useful, for example gabapentin (Neurontin Pfizer; dose rate 10-20mg/kg BID/TID – these are not licenced for dogs). Oral opioids, e.g. pethidine or methadone are also an alternative.

Drugs which reduce CSF production
Proton pump inhibitors such as omeprazole (Losec or Prilosec) can inhibit cerebrospinal fluid formation and therefore may be valuable; clinical data on their use and effectiveness for SM is currently lacking. This drug is unlikely to be useful in the long term as therapy longer than 8 weeks duration is not recommended as this may increase the risk for stomach cancer. Carbonic anhydrase inhibitors such as acetazolamide (Diamox; Lederle laboratories) also decrease CSF flow and may also be helpful in treating syringomyelia although adverse effects of abdominal pain, lethargy and weakness may limit long term use. Furosemide also decreases intracranial pressure and therefore could be useful in the treatment of syringomyelia. The mechanism of action is unknown and may just be due to diuresis and reduction in blood volume
At present the usefulness of omeprazole, acetazolamide and furosemide for treating syringomyelia is unknown.

Corticosteroids
Corticosteroids are anecdotally very effective in reducing both pain and neurological deficits although the exact mechanism is not known. It has been suggested that these drugs reduce CSF pressure however laboratory evidence of this is lacking. They possibly have a direct effect on pain mediators such as substance P. Although corticosteroids may be effective in limiting the signs and progression, most dogs require continuous therapy and subsequently develop the concomitant side effects of immunosuppression, weight gain and skin changes. If there is no alternative then the lowest possible dose that can control signs is used. Alternate day therapy is preferred. The author starts with 0.5mg/kg prednisolone / methylprednisolone daily.

Surgical management
Surgical management is indicated for dogs with significant pain or with worsening neurological signs. The aim is to restore CSF dynamics and if this can be achieved then the syrinx can resolve. The most common procedure for Chiari like malformation is suboccipital decompression where the hypoplastic occipital bone and sometimes the cranial dorsal laminae of the atlas are removed (with or without a durotomy) to decompress the foramen magnum. The success reported in the small case series varies from no improvement to post operative resolution of the syrinx. Syringo-subarachnoid shunting has also been described. In the author’s experience surgery is usually successful at significantly reducing the pain but some dogs may still show signs of discomfort /scratching. Also in the author’s experience signs may recur in a proportion of dogs after several months/years due to redevelopment of syringomyelia.
One must weigh the risks and benefits of surgery versus medication versus no intervention. Remember, progressive disease means that no action may enable further deterioration.

When to have surgery?
There is more chance of success if the surgery is done early in the course of the disease before permanent damage has occurred. Surgical management is indicated for dogs with significant pain or with worsening neurological signs

What are the risks of surgery?
There are major blood vessels in the area and if traumatised the dog could quickly bleed to death. Although not actually operating on the brain/spinal cord, it is in close proximity and there is a risk of permanent neurological injury. In reality complications from surgery seem to be rare.

Can the disease recur?
In the authors’ experience signs may recur in a proportion of dogs after several months/years due to redevelopment of syringomyelia. The newly created “space” from surgery may fill in with scar tissue. If this happens, repeat surgery may be indicated; some owner prefer to continue with medical management e.g. with NSAIDs, gabapentin or corticosteroids.

What post surgery drug treatment would you advise?
Dogs are hospitalised until comfortable enough for morphine-like-drugs to be discontinued and then discharged on a combination of non steroidal anti-inflammatory drugs (e.g. Rimadyl) and gabapentin (Neurontin). This is withdrawn when the dog is comfortable (about 2 weeks in most cases).

DNA collection programme

Our aim is to provide a comprehensive, integrated collection of cavalier King Charles spaniel DNA for the benefit of the dogs, owners, breeders and to provide insight into human disease. Surplus blood from a health check would be stored for future studies on the health of the breed. The current studies include syringomyelia (SM), mitral valve disease (MVD) and Epilepsy.

Questions & Answers

Why is blood needed?
It is easy to extract DNA from the white blood cells in a blood sample. To do this the blood must be fresh and prevented from clotting by putting it in an EDTA tube.

What will happen to the blood sample from my dog?
The DNA sample being submitted to the researchers will be anonymous once it is entered into the archive and will be kept strictly confidential. The samples and clinical data will be made to available to bona fide research groups working on these conditions and where the projects have been deemed to be ethically sound. The owner will also retain the right to remove the sample from the archive in the future if so wished. However, no information regarding tests performed on the DNA sample will be given back to the owner. It will only be possible to find out which genes and environmental factors are important by identifying patterns in large numbers of affected and unaffected animals.

What kinds of dogs are needed to give blood?
All blood from your cavaliers will be valued. The purpose of the study is to identify a gene through DNA analysis. We are therefore focusing on certain areas to be most successful in achieving our goal. We need dogs that are

• Normal healthy, especially if over 7years or MRI confirmed normal (no SM)
• Champions that often appear in pedigrees (any age)
• SM Affected –MRI confirmed or showing typical clinical signs
• Parents and siblings of affected dogs
• Offspring of affected dogs – If <3 years of age the blood may be stored in case signs develop later.
• Mates of an affected dog – is helpful if DNA from offspring is collected later
• MVD affected and their relatives (see SM above)

Remember
Your blood donation will help keep Cavaliers healthy from inherited diseases.

SM/MVD carriers can have good genes/characteristics that we need to conserve.

The more help we get the speedier will be the result.

Why do I need to provide a pedigree?
Pedigree information about your cavalier is important for our study. The relationship between affected and non affected family members can indicate the way in which a disease can be inherited. Comparisons are made between the parental genotypes and those of the offspring. Pedigree analysis is not sufficient in itself to determine if a trait is inherited as a threshold trait. There are many investigations to be made and that is why you are asked for as much blood (DNA) as possible. Linkage may be used, which means DNA from animals that link up affected individuals would be needed.

Bottom line: It is essential that we have DNA from related dogs regardless of whether their status is known.


If you want to donate cavalier blood, you can do so from the UK/Europe or the US/Canada.

For forms and info on donating from Europe, click the 'health' and 'syringomyelia' sections here: http://www.thecavalierclub.co.uk/start.html

For the US/Canada:

DNA may be in the form of EDTA blood (as much as possible ideally 5-10mls) or a DNA swab. Blood is preferred as more DNA can be extracted with this method.

USA forms: http://www.cavalierhealthfoundation....ns%20Forms.pdf

DNA swab kits are available either through the American Kennel Club http://www.akc.org/store/detail/index.cfm or from the International Canine Semen Bank http://www.ik9sb.com/index.htm.

It is essential that pedigree information and the phenotype form are filled in for each dog sampled, otherwise the valuable DNA cannot be used.

The DNA sample and the phenotype forms should be sent to
Berge A Minassian MD, CM FRCP(C)
Room 6536B
Hospital for Sick Children
555 University Ave. Toronto, Ontario
M5G 1X8 Canada
Tel: 416-813-6291
Fax: 416-813-6334
email: bminass@sickkids.ca

Please post /fax or email duplicate phenotype forms with pedigree information to
Clare Rusbridge
Stone Lion Veterinary Centre
41 High Street,
Wimbledon,
SW19 5AU, UK.
Confidential fax line 00 44 208 7860525
email: neuro.vet@btinternet.com